EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model

Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi iD, Yoshinori Hasegawa, Yuichi Wakabayashi iD

Cancer Science · 2024

DOI: 10.1111/cas.16246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Kazuhiro Okumura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan. Hauptthemen laut MEDLINE: p21-Activated Kinases, Skin Neoplasms, Carcinoma, Squamous Cell, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

By taking advantage of forward genetic analysis in mice, we have demonstrated that Pak1 plays a crucial role during DMBA/TPA skin carcinogenesis. Although Pak1 has been considered to promote cancer development, its overall function remains poorly understood. To clarify the functional significance of Pak1 in detail, we sought to evaluate the possible effect of an allosteric inhibitor against PAK1 (NVS‐PAK1‐1) on a syngeneic mouse model. To this end, we established two cell lines, 9AS1 and 19AS1, derived from DMBA/TPA‐induced squamous cell carcinoma (SCC) that engrafted in FVB mice. Based on our present results, NVS‐PAK1‐1 treatment significantly inhibited the growth of tumors derived from 9AS1 and 19AS1 cells in vitro and in vivo. RNA‐sequencing analysis on the engrafted tumors indicates that NVS‐PAK1‐1 markedly potentiates the epidermal cell differentiation and enhances the immune response in the engrafted tumors. Consistent with these observations, we found an expansion of Pan‐keratin‐positive regions and potentially elevated infiltration of CD8‐positive immune cells in NVS‐PAK1‐1‐treated tumors as examined by immunohistochemical analyses. Together, our present findings strongly suggest that PAK1 is tightly linked to the development of SCC, and that its inhibition is a promising therapeutic strategy against SCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

p21-Activated KinasesSkin NeoplasmsCarcinoma, Squamous CellDisease Models, AnimalAnimalsMiceCell Line, Tumor9,10-Dimethyl-1,2-benzanthraceneFemaleCell DifferentiationTetradecanoylphorbol AcetateCD8-Positive T-LymphocytesCell Proliferation

Stichwörter der Autor:innen

DMBA/TPAPAK1 inhibitormousesquamous cell carcinomasyngenic model

Substanzen

p21-Activated KinasesPak1 protein, mouse9,10-Dimethyl-1,2-benzanthraceneTetradecanoylphorbol Acetate

Autor:innen und Institutionen

  • Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.

ORCID-Profile: Yosuke Togashi, Yuichi Wakabayashi

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Foundation

Zitieren

APA

Okumura, K., Morinaga, T., Saito, M., Tokunaga, Y., Otoyama, K., Tanaka, S., Isogai, E., Kawazu, M., Togashi, Y., Hasegawa, Y., & Wakabayashi, Y. (2024). Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer Science. https://doi.org/10.1111/cas.16246

Vancouver

Okumura K, Morinaga T, Saito M, Tokunaga Y, Otoyama K, Tanaka S, et al. Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer Science. 2024. doi:10.1111/cas.16246

BibTeX
@article{Okumura2024,
  author = {Okumura, Kazuhiro and Morinaga, Takao and Saito, Megumi and Tokunaga, Yurika and Otoyama, Keisuke and Tanaka, Sora and Isogai, Eriko and Kawazu, Masahito and Togashi, Yosuke and Hasegawa, Yoshinori and Wakabayashi, Yuichi},
  title = {Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16246}
}
Kostenlos starten →